Tempus AI
Tracked across 5 events · 47 articles · First seen Jun 24, 2026 · Last active Aug 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Tempus AI expands its precision oncology platform and MRD capabilities, expected to drive future growth and market share.
Jul 20, 2026 · 18 articles
Business
Impact: Tempus AI is the central company in this event. It reported strong Q2 earnings and announced a major acquisition, but insider sales and a declining stock price temper positive sentiment.
Jul 30, 2026 · 7 articles
Tech
Impact: Named leader in discovery and clinical development AI, potentially boosting its market credibility.
Aug 10, 2026 · 6 articles
Business
Impact: Tempus AI is mentioned as a prior partner, indicating an existing relationship with Median Technologies, but is not directly involved in this agreement.
Jul 30, 2026 · 8 articles
Business
Impact: Acquired Paige AI for $81.25 million to expand AI pathology capabilities.
Jun 24, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Tempus AI live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard